Annan naturvetenskaplig och teknisk forskning och utveckling SNI 72109
I branschen Annan naturvetenskaplig och teknisk forskning och utveckling finns 1 360 aktiebolag med årsredovisningsdata. Visar plats 101–200, sorterade på omsättning.
1 360
aktiebolag
6376.2 M
kr i samlad omsättning
2 454
anställda
10.6%
median rörelsemarginal
Bolag — plats 101–200 efter omsättning
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 101 | Novista of Sweden AB | 5.7 M | -918.8 k | -15.8% | 3 |
| 102 | Skansen Technologies AB | 5.5 M | -48.1 M | -499.0% | 13 |
| 103 | HILICON AB | 5.3 M | 404.9 k | 7.5% | 1 |
| 104 | Capra Science Antibodies AB | 5.2 M | 235.3 k | 4.4% | 3 |
| 105 | JAMCO Pharma Consulting AB | 5.2 M | 3.3 M | 63.0% | 2 |
| 106 | Qlocx Digital AB | 5.1 M | -146.8 k | -2.9% | 1 |
| 107 | ALMO ALO AB | 5.0 M | 3.2 M | 64.6% | 2 |
| 108 | Craven-Bartle Optical Engineering AB | 5.0 M | 2.6 M | 53.1% | 2 |
| 109 | Dosell AB | 4.9 M | -8.9 M | -182.6% | 5 |
| 110 | Moell Konsult AB | 4.8 M | 413.2 k | 8.5% | 2 |
| 111 | NMS Research Center Sweden AB | 4.8 M | 31.6 k | 0.7% | 3 |
| 112 | Ginolis AB | 4.5 M | 43.2 k | 1.0% | — |
| 113 | Corpremans Clinical Trial Consultancy AB | 4.4 M | 1.6 M | 35.0% | 4 |
| 114 | Preventia Aktiebolag | 4.3 M | -52.2 k | -1.2% | 2 |
| 115 | ZAFENA Aktiebolag | 4.2 M | -814.7 k | -19.5% | 3 |
| 116 | Metacomp Technologies Sweden AB | 4.2 M | 34.6 k | 0.8% | 2 |
| 117 | OT Pharmaceuticals AB | 4.1 M | 1.2 M | 27.8% | 1 |
| 118 | Blazing Terra AB | 4.1 M | 1.2 M | 19.3% | 4 |
| 119 | Hot Disk Sensor Technology AB | 4.1 M | 170.7 k | 4.2% | — |
| 120 | RQV Teknik AB | 4.0 M | 1.1 M | 26.6% | 2 |
| 121 | VWH & Company Aktiebolag | 3.7 M | 606.0 k | 16.3% | 3 |
| 122 | ETVAX AB | 3.7 M | -14.1 M | -12.8% | 34 |
| 123 | NILU Klimat- och miljöinstitutet AB | 3.7 M | -2.2 M | -60.2% | 3 |
| 124 | IQ Samhällsbyggnad AB | 3.6 M | 705.6 k | 2.6% | 11 |
| 125 | Gherman Research & Development AB | 3.6 M | 565.5 k | 15.6% | 1 |
| 126 | Sownder AB | 3.5 M | 953.6 k | 17.9% | 4 |
| 127 | Nordmark Clin Pharm Consulting AB | 3.4 M | 2.0 M | 52.4% | 1 |
| 128 | Mediqip AB | 3.4 M | 187.7 k | 5.5% | 1 |
| 129 | TÜV NORD Scandinavia Medical Notified Body AB | 3.4 M | -25.8 M | -751.9% | — |
| 130 | Evoma AB | 3.4 M | -1.2 M | -24.3% | 5 |
| 131 | AB Swiftstrike AI | 3.3 M | 1.2 M | 36.0% | 2 |
| 132 | Luts Läkarkonsult AB | 3.1 M | 50.0 k | 1.4% | 1 |
| 133 | PlayReplay AB | 3.1 M | -12.1 M | -86.8% | 10 |
| 134 | VIMA AB | 3.1 M | 1.8 M | 56.3% | 2 |
| 135 | Joel Siljeskog Konsult AB | 3.1 M | 529.4 k | 17.0% | 2 |
| 136 | Lundoch Diagnostics AB | 3.1 M | 496.1 k | 14.9% | — |
| 137 | Christina PV-Pharma Consulting AB | 3.1 M | 2.6 M | 83.9% | 2 |
| 138 | Gutschy Medical Partners AB | 3.1 M | 564.8 k | 18.2% | 2 |
| 139 | Xray Intellect AB | 2.9 M | 1.6 M | 54.4% | 1 |
| 140 | Emplicure Consumer AB | 2.8 M | -90.6 M | -2881.3% | 23 |
| 141 | noncomplicity AB | 2.8 M | 1.1 M | 37.7% | 2 |
| 142 | AdvanSci Research Solutions AB | 2.7 M | 126.9 k | 4.7% | 4 |
| 143 | Legado Bioresearch AB | 2.7 M | 131.0 k | 4.8% | 2 |
| 144 | OSSEOFON AB | 2.7 M | 2.7 M | 99.2% | — |
| 145 | Salbo Konsult AB | 2.7 M | 969.7 k | 34.2% | 2 |
| 146 | HYLANDERS GEO-BYRÅ AKTIEBOLAG | 2.7 M | 1.6 M | 58.3% | 1 |
| 147 | MIX Research Sweden AB | 2.6 M | 197.1 k | 7.5% | 3 |
| 148 | PRONEXUS ANALYTICAL AB | 2.6 M | -1.1 M | -41.9% | 4 |
| 149 | APODEMUS AKTIEBOLAG | 2.6 M | 79.5 k | 3.1% | — |
| 150 | CareLigo AB | 2.5 M | -187.9 k | -7.1% | 4 |
| 151 | Akitemos Solutions AB | 2.5 M | 230.8 k | 8.0% | — |
| 152 | FOLLOU AB | 2.5 M | 699.6 k | 28.1% | 1 |
| 153 | HÄLSOJOUREN BERENS & HALLMIN AKTIEBOLAG | 2.5 M | 505.2 k | 20.5% | 2 |
| 154 | Sweden Quantum AB | 2.5 M | 33.6 k | 1.3% | 1 |
| 155 | NanoScientifica Scandinavia AB | 2.4 M | 122.7 k | 5.0% | 2 |
| 156 | Fashi Media AB | 2.4 M | -291.1 k | -11.9% | 3 |
| 157 | BALD Engineering AB | 2.4 M | 1.0 M | 42.1% | — |
| 158 | Svenska arkitekturinstitutet AB (svb) | 2.4 M | 231.1 k | 9.7% | 2 |
| 159 | Dentacore AB | 2.4 M | 1.4 M | 57.7% | 1 |
| 160 | Bengt Lindoff Innovation AB | 2.4 M | 593.0 k | 25.1% | 2 |
| 161 | Rapp RF Design AB | 2.3 M | 1.1 M | 47.7% | 1 |
| 162 | MONQURA AB | 2.3 M | 1.1 M | 47.0% | — |
| 163 | PVM Consulting AB | 2.3 M | 769.8 k | 33.1% | 2 |
| 164 | Tefting AB | 2.3 M | 2.0 M | 87.1% | 1 |
| 165 | GG Cure Consulting AB | 2.3 M | 1.3 M | 59.1% | 2 |
| 166 | NEOKO AB | 2.2 M | 523.8 k | 23.4% | 1 |
| 167 | BioReperia AB | 2.2 M | -5.3 M | -189.4% | 8 |
| 168 | Junvik Consulting AB | 2.2 M | 890.1 k | 39.9% | 1 |
| 169 | Allmora Life Science AB | 2.2 M | 1.6 M | 71.1% | 1 |
| 170 | P&L Scientific AB | 2.2 M | 616.0 k | 25.4% | 1 |
| 171 | Sangus Jazz AB | 2.2 M | 745.6 k | 34.1% | 1 |
| 172 | Furberg Richard Energy Engineering AB | 2.2 M | 954.4 k | 43.9% | 1 |
| 173 | FREDLUND OLSSON QA AUDITS AB | 2.2 M | 505.7 k | 22.8% | 1 |
| 174 | JK Biostatistics AB | 2.2 M | 209.6 k | 9.7% | 3 |
| 175 | PDS Consulting AB | 2.2 M | 519.4 k | 24.1% | 1 |
| 176 | Arexela AB | 2.1 M | 1.4 M | 67.2% | — |
| 177 | Floristgaraget Sthlm & Burén Konsult AB | 2.1 M | 1.1 M | 53.0% | 1 |
| 178 | Envinn AB | 2.1 M | 495.2 k | 22.5% | 2 |
| 179 | J Bexelius Consulting AB | 2.1 M | 1.0 M | 48.6% | 1 |
| 180 | Eirino AB | 2.1 M | 623.9 k | 30.1% | 1 |
| 181 | Vargas Engineering AB | 2.1 M | 1.1 M | 53.6% | 1 |
| 182 | Kellie Konsult AB | 2.1 M | 1.1 M | 51.6% | 1 |
| 183 | SEPRANKER CONSULTING AB | 2.1 M | 1.8 M | 66.9% | — |
| 184 | ZEmission AB | 2.0 M | 379.0 k | 13.4% | 3 |
| 185 | D2MED Consulting AB | 2.0 M | 448.3 k | 22.4% | — |
| 186 | Nordic Pharma Consultant AB | 2.0 M | 782.8 k | 39.8% | 1 |
| 187 | Levander Life Science Consulting AB | 1.9 M | 49.4 k | 2.5% | 2 |
| 188 | SCANIA VITALIS AB | 1.9 M | 1.6 M | 80.3% | 1 |
| 189 | JP Project Management AB | 1.9 M | 477.2 k | 24.8% | 1 |
| 190 | Psycurum AB | 1.9 M | 1.6 M | 73.5% | 1 |
| 191 | Hallvall Clinical Consulting AB | 1.9 M | 398.0 k | 20.8% | 1 |
| 192 | NEUROGYN NORR AB | 1.9 M | 509.3 k | 26.7% | 1 |
| 193 | Gigascan Technologies AB | 1.9 M | 299.6 k | 8.0% | 2 |
| 194 | IMACOMP CONSULTING AB | 1.9 M | -5.3 k | -0.3% | 1 |
| 195 | Fravil Clinical Consulting AB | 1.9 M | 863.8 k | 45.5% | 1 |
| 196 | RefinyX AB | 1.9 M | 236.9 k | 11.0% | 1 |
| 197 | VixiMed AB | 1.9 M | -95.0 k | -5.1% | 1 |
| 198 | BioLogical Solutions Stockholm AB | 1.9 M | 1.5 M | 78.4% | — |
| 199 | Terra Mobile Consultants AB | 1.9 M | 454.8 k | 24.4% | 1 |
| 200 | Kron Byggkonsult AB | 1.9 M | 469.3 k | 25.3% | 1 |
101–200 av 1 360 bolag · sida 2 av 14